Centaurea damascena in alloxan-induced diabetes in rats

B. H. Ali*, A. K. Bashir, R. A. Rasheed

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


We examined the effect of treatment of alloxan-diabetic rats with a lyophilised extract of Centaurea damascena Bioss. (family Compositae), a plant that is reputed in certain parts of the Middle East to have an antidiabetic effect. Its effect was compared with those of the conventional oral hypoglycaemic drug glibenclamide (10 mg kg-1). The plasma glucose concentrations of diabetic rats treated orally with the plant extract (0.5, 1 or 2 g kg-1) were not significantly different from the controls. Also, the plasma glucose level did not differ from that of the controls in rats given the extract (2 g kg-1), and killed 0.5, 2 or 3 h after treatment with the plant extract. Glibenclamide was effective in significantly reducing the alloxan-induced hyperglycaemia.

Original languageEnglish
Pages (from-to)493-494
Number of pages2
JournalMedical Science Research
Issue number7
Publication statusPublished - 1997


  • Alloxan-diabetes
  • Antidiabetic plants
  • Centaurea damascena
  • Glibenclamide

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Centaurea damascena in alloxan-induced diabetes in rats'. Together they form a unique fingerprint.

Cite this